[1]Holzfurtner L,Shahzad T,Dong Y et al.When inflamma-tion meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia[J].Mol Cell Pediatr,2022,9:7.doi: 10.1186/s40348-022-00137-z. [2]Helmo FR,Rodovalho Alves EA,de Andrade Moreira RA,et al.Intrauterine infection, immune system and premature birth[J].J Matern Fetal Neonatal Med,2018,31:1227-1233. [3]Mi LL,Guo WW.Crosstalk between ILC2s and Th2 CD4 T Cells in lung disease+[J].J Immunol Res, 2022,2022:8871037. doi: 10.1155/2022/8871037. [4]Mi LL,Zhu SX,Cai JY,et al.Tissue-resident type 2 innate lymphoid cells arrest alveolarization in bronchopulmonary dysplasia[J].J Immunol Res,2020,2020:8050186. doi: 10.1155/2020/8050186. [5]Tian W,Jiang XG,Kim D,et al.Leukotrienes in tumor-associated inflammation[J].Front Pharmacol, 2020,11:1289.doi: 10.3389/fphar.2020.01289. [6]Nardiello C,Miíková L,Silva DM,et al.Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia[J].Dis Model Mech,2017,10:185-196. [7]Loering S,Gameron GJM,Starkey MR.Lung development and emerging roles for type 2 immunity[J].J Pathol,2019,247:686-696. [8]Lao JC,Bui CB,Pang MA,et al.Type 2 immune polariza-tion is associated with cardiopulmonary disease in preterm infants[J].Sci Transl Med,2022,14:eaaz8454.doi: 10.1126/scitranslmed.aaz8454. [9]Mirro R,Armstead W,Leffler C. Increased airway leuktriene levels in infants with severe bronchopulmonary dysplasia[J]. Am J Dis Child,1990,144:160-161. [10]金蕊,卢红艳,罗炎炎,等.尿半胱氨酸白三烯E4诊断支气管肺发育不良的临床评价[J].中华儿科杂志,2016,54:703-707. [11]Tieng EM,Kantores C,Ivanovska J,et al.Leukotriene B4 mediates macrophage influx and pulmonary hypertension in bleomycin-induced chronic neonatal lung injury[J].Am J Physiol Lung Cell Mol Physiol,2016,311:292-302. [12]Lund SJ,Portillo A,Cavagnero K,et al.Leukotriene C4 potentiates IL-33-induced group 2 innate lymphoid cell activation and lung inflammation[J].J Immunol,2017,199:1096-1104. [13]Drake LY,Kita H.Group 2 innate lymphoid cells in the lung[J].Adv Immunol,2014,124:1-16. [14]Jin J,Sunusi S,Lu HY.Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target[J].J Int Med Res,2022,50:3000605211053156. doi: 10.1177/03000605211053156. |